{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:58:36Z","timestamp":1774403916010,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-026-02477-1","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T11:14:57Z","timestamp":1771586097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Higher Serum Levels of Propionylcarnitine and Methionine are Associated with Reduced Cortical Amyloid Burden in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"76","author":[{"given":"Qamar","family":"Abuhassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghaleb","family":"Oriquat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumya V.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laxmidhar","family":"Maharana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Inbathamizh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunjan","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aashna","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shokhjakhon","family":"Furkatov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) and the Alzheimer Disease Metabolomics Consortium (ADMC)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"2477_CR11","doi-asserted-by":"publisher","unstructured":"Abdulrazzaq SB, Abu-Samak M, Omar A, Barakat M, Alzaghari LF, Mosleh I et al (2024) The effect of vitamin D3 and omega-3 combination, taken orally, on triglycerides, lining of intestine, and the biodiversity of gut microbiota in healthy rats. J Appl Microbiol 135(9). https:\/\/doi.org\/10.1093\/jambio\/lxae223","DOI":"10.1093\/jambio\/lxae223"},{"issue":"1","key":"2477_CR52","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.1038\/s41598-024-56622-0","volume":"14","author":"MAA Al-Najjar","year":"2024","unstructured":"Al-Najjar MAA, Abdulrazzaq SB, Alzaghari LF, Mahmod AI, Omar A, Hasen E et al (2024) Evaluation of Immunomodulatory potential of probiotic conditioned medium on murine macrophages. Sci Rep 14(1):7126. https:\/\/doi.org\/10.1038\/s41598-024-56622-0","journal-title":"Sci Rep"},{"issue":"1","key":"2477_CR58","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41467-020-14959-w","volume":"11","author":"M Arnold","year":"2020","unstructured":"Arnold M, Nho K, Kueider-Paisley A, Massaro T, Huynh K, Brauner B et al (2020) Sex and APOE \u03b54 genotype modify the alzheimer\u2019s disease serum metabolome. Nat Commun 11(1):1148. https:\/\/doi.org\/10.1038\/s41467-020-14959-w","journal-title":"Nat Commun"},{"key":"2477_CR24","first-page":"27","volume":"27","author":"E Arrigoni-Martelli","year":"2001","unstructured":"Arrigoni-Martelli E, Caso V (2001) Carnitine protects mitochondria and removes toxic acyls from xenobiotics. Drugs Under Exp Clin Res 27:27\u201349","journal-title":"Drugs Under Exp Clin Res"},{"key":"2477_CR36","unstructured":"Azargoonjahromi A (2018) Abstract of medical biochemistry (Metabolism). Harper-Lehninger-Devlin"},{"key":"2477_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.niox.2023.03.003","volume":"134\u2013135","author":"A Azargoonjahromi","year":"2023","unstructured":"Azargoonjahromi A (2023) Dual role of nitric oxide in alzheimer\u2019s disease. Nitric Oxide 134\u2013135:23\u201337. https:\/\/doi.org\/10.1016\/j.niox.2023.03.003","journal-title":"Nitric Oxide"},{"issue":"1","key":"2477_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13041-024-01118-1","volume":"17","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A (2024) The duality of amyloid-\u03b2: its role in normal and alzheimer\u2019s disease States. Mol Brain 17(1):44. https:\/\/doi.org\/10.1186\/s13041-024-01118-1","journal-title":"Mol Brain"},{"key":"2477_CR6","doi-asserted-by":"crossref","unstructured":"Azargoonjahromi A, Ashrafi M, Abroushan D, Ramezannezhad E, Sadeghi M, Pooresmaeil Niaki SR et al High-Density lipoprotein (HDL) subtypes adversely alter brain structure in mild cognitive impairment: A Tensor-Based morphometry analysis. MedRxiv. 2024:2024.08. 20.24312114.","DOI":"10.1101\/2024.08.20.24312114"},{"key":"2477_CR37","doi-asserted-by":"publisher","first-page":"100876","DOI":"10.1016\/j.phyplu.2025.100876","volume":"5","author":"M Barakat","year":"2025","unstructured":"Barakat M, Thiab S, Alzaghari L, Abdulrazzaq S, Hasen E, Feras Abuarab S et al (2025) Cannabis and the immune response: A comprehensive review of therapeutic potential and concerns. Phytomedicine Plus 5:100876. https:\/\/doi.org\/10.1016\/j.phyplu.2025.100876","journal-title":"Phytomedicine Plus"},{"key":"2477_CR51","doi-asserted-by":"publisher","unstructured":"Bekdash RA, Methyl, Donors (2023) Epigenetic Alterations, and brain health: Understanding the connection. Int J Mol Sci 24(3). https:\/\/doi.org\/10.3390\/ijms24032346","DOI":"10.3390\/ijms24032346"},{"issue":"2","key":"2477_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2165\/00126839-200809020-00003","volume":"9","author":"TL Broderick","year":"2008","unstructured":"Broderick TL (2008) ATP production and TCA activity are stimulated by propionyl-L-carnitine in the diabetic rat heart. Drugs R D 9(2):83\u201391. https:\/\/doi.org\/10.2165\/00126839-200809020-00003","journal-title":"Drugs R D"},{"issue":"4","key":"2477_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2165\/00126839-200405040-00002","volume":"5","author":"TL Broderick","year":"2004","unstructured":"Broderick TL, Paulson DJ, Gillis M (2004) Effects of propionyl-carnitine on mitochondrial respiration and post-ischaemic cardiac function in the ischaemic underperfused diabetic rat heart. Drugs R D 5(4):191\u2013201. https:\/\/doi.org\/10.2165\/00126839-200405040-00002","journal-title":"Drugs R D"},{"key":"2477_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/8904_2016_21","volume":"35","author":"G Cappuccio","year":"2017","unstructured":"Cappuccio G, Atwal PS, Donti TR, Ugarte K, Merchant N, Craigen WJ et al (2017) Expansion of the phenotypic spectrum of propionic acidemia with isolated elevated Propionylcarnitine. JIMD Rep 35:33\u201337. https:\/\/doi.org\/10.1007\/8904_2016_21","journal-title":"JIMD Rep"},{"issue":"4","key":"2477_CR27","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2967\/jnumed.114.149732","volume":"56","author":"K Chen","year":"2015","unstructured":"Chen K, Roontiva A, Thiyyagura P, Lee W, Liu X, Ayutyanont N et al (2015) Improved power for characterizing longitudinal amyloid-\u03b2 PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region. J Nucl Med 56(4):560\u2013566. https:\/\/doi.org\/10.2967\/jnumed.114.149732","journal-title":"J Nucl Med"},{"key":"2477_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2016.03.005","volume":"43","author":"D Ciavardelli","year":"2016","unstructured":"Ciavardelli D, Piras F, Consalvo A, Rossi C, Zucchelli M, Di Ilio C et al (2016) Medium-chain plasma acylcarnitines, ketone levels, cognition, and Gray matter volumes in healthy elderly, mildly cognitively impaired, or alzheimer\u2019s disease subjects. Neurobiol Aging 43:1\u201312. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.03.005","journal-title":"Neurobiol Aging"},{"key":"2477_CR43","doi-asserted-by":"publisher","first-page":"102713","DOI":"10.1016\/j.arr.2025.102713","volume":"107","author":"MCB D\u2019Alessandro","year":"2025","unstructured":"D\u2019Alessandro MCB, Kanaan S, Geller M, Pratic\u00f2 D, Daher JPL (2025) Mitochondrial dysfunction in alzheimer\u2019s disease. Ageing Res Rev 107:102713. https:\/\/doi.org\/10.1016\/j.arr.2025.102713","journal-title":"Ageing Res Rev"},{"issue":"1","key":"2477_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13195-017-0270-x","volume":"9","author":"L Dayon","year":"2017","unstructured":"Dayon L, Guiraud SP, Corth\u00e9sy J, Da Silva L, Migliavacca E, Tautvydait\u0117 D et al (2017) One-carbon metabolism, cognitive impairment and CSF measures of alzheimer pathology: homocysteine and beyond. Alzheimers Res Ther 9(1):43. https:\/\/doi.org\/10.1186\/s13195-017-0270-x","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2477_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","volume":"25","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Rabinowitz JD (2017) One-Carbon metabolism in health and disease. Cell Metab 25(1):27\u201342. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.009","journal-title":"Cell Metab"},{"key":"2477_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejphar.2008.09.001","volume":"597","author":"R Epis","year":"2008","unstructured":"Epis R, Marcello E, Gardoni F, Longhi A, Calvani M, Iannuccelli M et al (2008) Modulatory effect of acetyl-L-carnitine on amyloid precursor protein metabolism in hippocampal neurons. Eur J Pharmacol 597:51\u201356. https:\/\/doi.org\/10.1016\/j.ejphar.2008.09.001","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"2477_CR34","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s11064-017-2288-7","volume":"42","author":"GC Ferreira","year":"2017","unstructured":"Ferreira GC, McKenna MC (2017) L-Carnitine and Acetyl-L-carnitine roles and neuroprotection in developing brain. Neurochem Res 42(6):1661\u20131675. https:\/\/doi.org\/10.1007\/s11064-017-2288-7","journal-title":"Neurochem Res"},{"issue":"11","key":"2477_CR28","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1001\/archneurol.2011.150","volume":"68","author":"AS Fleisher","year":"2011","unstructured":"Fleisher AS, Chen K, Liu X, Roontiva A, Thiyyagura P, Ayutyanont N et al (2011) Using positron emission tomography and Florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to alzheimer disease. Arch Neurol 68(11):1404\u20131411. https:\/\/doi.org\/10.1001\/archneurol.2011.150","journal-title":"Arch Neurol"},{"issue":"3","key":"2477_CR9","doi-asserted-by":"publisher","first-page":"glae283","DOI":"10.1093\/gerona\/glae283","volume":"80","author":"L Gutierrez-Tordera","year":"2025","unstructured":"Gutierrez-Tordera L, Panisello L, Garc\u00eda-Gonzalez P, Ruiz A, Cantero JL, Rojas-Criollo M et al (2025) Metabolic signature of insulin resistance and risk of alzheimer\u2019s disease. Journals Gerontology: Ser A 80(3):glae283. https:\/\/doi.org\/10.1093\/gerona\/glae283","journal-title":"Journals Gerontology: Ser A"},{"key":"2477_CR32","doi-asserted-by":"publisher","unstructured":"Held PK, Singh E, Scott Schwoerer J (2022) Screening for methylmalonic and propionic acidemia: clinical outcomes and Follow-Up recommendations. Int J Neonatal Screen 8(1). https:\/\/doi.org\/10.3390\/ijns8010013","DOI":"10.3390\/ijns8010013"},{"issue":"11","key":"2477_CR18","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1001\/jamapsychiatry.2019.1694","volume":"76","author":"B Hooshmand","year":"2019","unstructured":"Hooshmand B, Refsum H, Smith AD, Kalpouzos G, Mangialasche F, von Arnim CAF et al (2019) Association of methionine to homocysteine status with brain magnetic resonance imaging measures and risk of dementia. JAMA Psychiatry 76(11):1198\u20131205. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.1694","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"2477_CR7","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/alz.12468","volume":"18","author":"E Horgusluoglu","year":"2022","unstructured":"Horgusluoglu E, Neff R, Song WM, Wang M, Wang Q, Arnold M et al (2022) Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of alzheimer\u2019s disease. Alzheimers Dement 18(6):1260\u20131278. https:\/\/doi.org\/10.1002\/alz.12468","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2477_CR13","doi-asserted-by":"publisher","first-page":"103362","DOI":"10.1016\/j.retram.2022.103362","volume":"71","author":"CJC Huguenard","year":"2023","unstructured":"Huguenard CJC, Cseresznye A, Evans JE, Darcey T, Nkiliza A, Keegan AP et al (2023) APOE \u03b54 and alzheimer\u2019s disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain. Curr Res Transl Med 71(1):103362. https:\/\/doi.org\/10.1016\/j.retram.2022.103362","journal-title":"Curr Res Transl Med"},{"key":"2477_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2019.10.014","volume":"86","author":"Z Huo","year":"2020","unstructured":"Huo Z, Yu L, Yang J, Zhu Y, Bennett DA, Zhao J (2020) Brain and blood metabolome for alzheimer\u2019s dementia: findings from a targeted metabolomics analysis. Neurobiol Aging 86:123\u2013133. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.10.014","journal-title":"Neurobiol Aging"},{"key":"2477_CR49","doi-asserted-by":"publisher","unstructured":"Jia K, Tian J, Wang T, Guo L, Xuan Z, Swerdlow RH et al (2023) Mitochondria-sequestered A\u03b2 renders synaptic mitochondria vulnerable in the elderly with a risk of alzheimer disease. JCI Insight 8(22). https:\/\/doi.org\/10.1172\/jci.insight.174290","DOI":"10.1172\/jci.insight.174290"},{"key":"2477_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12090822","author":"M Kadyrov","year":"2022","unstructured":"Kadyrov M, Whiley L, Brown B, Erickson KI, Holmes E (2022) Associations of the lipidome with Ageing, cognitive decline and exercise behaviours. Metabolites. https:\/\/doi.org\/10.3390\/metabo12090822","journal-title":"Metabolites"},{"issue":"2","key":"2477_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3233\/jad-170991","volume":"63","author":"JK Kueper","year":"2018","unstructured":"Kueper JK, Speechley M, Montero-Odasso M (2018) The alzheimer\u2019s disease assessment Scale-Cognitive subscale (ADAS-Cog): modifications and responsiveness in Pre-Dementia Populations. A narrative review. J Alzheimers Dis 63(2):423\u2013444. https:\/\/doi.org\/10.3233\/jad-170991","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2477_CR59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00726-024-03442-1","volume":"57","author":"X Ma","year":"2025","unstructured":"Ma X, Wang XM, Tang GZ, Wang Y, Liu XC, Wang SD et al (2025) Alterations of amino acids in older adults with alzheimer\u2019s disease and vascular dementia. Amino Acids 57(1):10. https:\/\/doi.org\/10.1007\/s00726-024-03442-1","journal-title":"Amino Acids"},{"issue":"7","key":"2477_CR25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/wnl.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on alzheimer\u2019s disease. Neurology 34(7):939\u2013944. https:\/\/doi.org\/10.1212\/wnl.34.7.939","journal-title":"Neurology"},{"issue":"1","key":"2477_CR19","doi-asserted-by":"publisher","first-page":"12427","DOI":"10.1038\/s41598-022-16242-y","volume":"12","author":"A Mihara","year":"2022","unstructured":"Mihara A, Ohara T, Hata J, Chen S, Honda T, Tamrakar S et al (2022) Association of serum s-adenosylmethionine, s-adenosylhomocysteine, and their ratio with the risk of dementia and death in a community. Sci Rep 12(1):12427. https:\/\/doi.org\/10.1038\/s41598-022-16242-y","journal-title":"Sci Rep"},{"issue":"1","key":"2477_CR53","first-page":"7","volume":"8","author":"AL Miller","year":"2003","unstructured":"Miller AL (2003) The methionine-homocysteine cycle and its effects on cognitive diseases.(Homocysteine & Cognitive). Altern Med Rev 8(1):7\u201320","journal-title":"Altern Med Rev"},{"key":"2477_CR44","doi-asserted-by":"publisher","first-page":"617588","DOI":"10.3389\/fnagi.2021.617588","volume":"13","author":"A Misrani","year":"2021","unstructured":"Misrani A, Tabassum S, Yang L (2021) Mitochondrial dysfunction and oxidative stress in alzheimer\u2019s disease. Front Aging Neurosci 13:617588. https:\/\/doi.org\/10.3389\/fnagi.2021.617588","journal-title":"Front Aging Neurosci"},{"key":"2477_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00002093-199700112-00003","volume":"11","author":"RC Mohs","year":"1997","unstructured":"Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M et al (1997) Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the alzheimer\u2019s disease assessment scale that broaden its scope. Alzheimer Disease Assoc Disorders 11:13\u201321","journal-title":"Alzheimer Disease Assoc Disorders"},{"issue":"3","key":"2477_CR10","doi-asserted-by":"publisher","first-page":"fcab139","DOI":"10.1093\/braincomms\/fcab139","volume":"3","author":"K Nho","year":"2021","unstructured":"Nho K, Kueider-Paisley A, Arnold M, MahmoudianDehkordi S, Risacher SL, Louie G et al (2021) Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression. Brain Commun 3(3):fcab139. https:\/\/doi.org\/10.1093\/braincomms\/fcab139","journal-title":"Brain Commun"},{"issue":"1","key":"2477_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5214\/ans.0972.7531.2006.130103","volume":"13","author":"P Pandey","year":"2010","unstructured":"Pandey P, Pradhan S, Homocysteine (2010) A possible modifiable risk factor in vascular dementia. Annals Neurosciences 13(1):12\u201317","journal-title":"Annals Neurosciences"},{"issue":"12","key":"2477_CR39","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1002\/alz.13130","volume":"19","author":"DJ Panyard","year":"2023","unstructured":"Panyard DJ, McKetney J, Deming YK, Morrow AR, Ennis GE, Jonaitis EM et al (2023) Large-scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in alzheimer\u2019s disease. Alzheimers Dement 19(12):5447\u20135470. https:\/\/doi.org\/10.1002\/alz.13130","journal-title":"Alzheimers Dement"},{"issue":"3","key":"2477_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ et al (2010) Alzheimer\u2019s disease neuroimaging initiative (ADNI): clinical characterization. Neurology 74(3):201\u2013209. https:\/\/doi.org\/10.1212\/WNL.0b013e3181cb3e25","journal-title":"Neurology"},{"issue":"1","key":"2477_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/13872877251326553","volume":"105","author":"S-D Qiu","year":"2025","unstructured":"Qiu S-D, Zhang D-D, Ma L-Y, Li Q-Y, Wang L-Y, Wang Y-D et al (2025) Associations of metabolic syndrome with risks of dementia and cognitive impairment: A systematic review and meta-analysis. J Alzheimer\u2019s Disease 105(1):15\u201327. https:\/\/doi.org\/10.1177\/13872877251326553","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"11","key":"2477_CR30","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","volume":"141","author":"WG Rosen","year":"1984","unstructured":"Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for alzheimer\u2019s disease. Am J Psychiatry 141(11):1356\u20131364","journal-title":"Am J Psychiatry"},{"issue":"2","key":"2477_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/s0022-510x(97)00314-6","volume":"155","author":"JC Rubio","year":"1998","unstructured":"Rubio JC, de Bustos F, Molina JA, Jim\u00e9nez-Jim\u00e9nez FJ, Benito-Le\u00f3n J, Mart\u00edn MA et al (1998) Cerebrospinal fluid carnitine levels in patients with alzheimer\u2019s disease. J Neurol Sci 155(2):192\u2013195. https:\/\/doi.org\/10.1016\/s0022-510x(97)00314-6","journal-title":"J Neurol Sci"},{"key":"2477_CR2","doi-asserted-by":"publisher","unstructured":"Safiri S, Ghaffari Jolfayi A, Fazlollahi A, Morsali S, Sarkesh A, Daei Sorkhabi A et al (2024) Alzheimer\u2019s disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges. Front Med 11\u20132024. https:\/\/doi.org\/10.3389\/fmed.2024.1474043","DOI":"10.3389\/fmed.2024.1474043"},{"key":"2477_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094977","author":"K Sfakianoudis","year":"2024","unstructured":"Sfakianoudis K, Zikopoulos A, Grigoriadis S, Seretis N, Maziotis E, Anifandis G et al (2024) The role of One-Carbon metabolism and Methyl donors in medically assisted reproduction: A narrative review of the literature. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25094977","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2477_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13024-025-00849-6","volume":"20","author":"D Song","year":"2025","unstructured":"Song D, Li Y, Yang LL, Luo YX, Yao XQ (2025) Bridging systemic metabolic dysfunction and alzheimer\u2019s disease: the liver interface. Mol Neurodegener 20(1):61. https:\/\/doi.org\/10.1186\/s13024-025-00849-6","journal-title":"Mol Neurodegener"},{"key":"2477_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813977","author":"S Szrok-Jurga","year":"2023","unstructured":"Szrok-Jurga S, Turyn J, Hebanowska A, Swierczynski J, Czumaj A, Sledzinski T et al (2023) The role of Acyl-CoA \u03b2-Oxidation in brain metabolism and neurodegenerative diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241813977","journal-title":"Int J Mol Sci"},{"key":"2477_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-015-0057-0","volume":"10","author":"C Tapia-Rojas","year":"2015","unstructured":"Tapia-Rojas C, Lindsay CB, Montecinos-Oliva C, Arrazola MS, Retamales RM, Bunout D et al (2015) Is L-methionine a trigger factor for Alzheimer\u2019s-like neurodegeneration? Changes in A\u03b2 oligomers, Tau phosphorylation, synaptic proteins, Wnt signaling and behavioral impairment in wild-type mice. Mol Neurodegener 10:62. https:\/\/doi.org\/10.1186\/s13024-015-0057-0","journal-title":"Mol Neurodegener"},{"issue":"8","key":"2477_CR48","doi-asserted-by":"publisher","first-page":"10856","DOI":"10.1007\/s12035-025-04936-z","volume":"62","author":"J Tian","year":"2025","unstructured":"Tian J, Mao Y, Liu D, Li T, Wang Y, Zhu C (2025) Mitophagy in brain injuries: Mechanisms, Roles, and therapeutic potential. Mol Neurobiol 62(8):10856\u201310868. https:\/\/doi.org\/10.1007\/s12035-025-04936-z","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2477_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13195-019-0551-7","volume":"11","author":"V van der Velpen","year":"2019","unstructured":"van der Velpen V, Teav T, Gallart-Ayala H, Mehl F, Konz I, Clark C et al (2019) Systemic and central nervous system metabolic alterations in alzheimer\u2019s disease. Alzheimers Res Ther 11(1):93. https:\/\/doi.org\/10.1186\/s13195-019-0551-7","journal-title":"Alzheimers Res Ther"},{"key":"2477_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/biom15020216","author":"M Volpicella","year":"2025","unstructured":"Volpicella M, Sgobba MN, Laera L, Francavilla AL, De Luca DI, Guerra L et al (2025) Carnitine O-Acetyltransferase as a central player in lipid and Branched-Chain amino acid Metabolism, Epigenetics, cell Plasticity, and organelle function. Biomolecules. https:\/\/doi.org\/10.3390\/biom15020216","journal-title":"Biomolecules"},{"issue":"5","key":"2477_CR60","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.ajcnut.2024.08.027","volume":"120","author":"Y Wang","year":"2024","unstructured":"Wang Y, Mi N, Liao K, Li Y, Sun Y, Xie P et al (2024) Associations among dietary 1-carbon metabolism nutrients, genetic risk, and alzheimer disease: a prospective cohort study. Am J Clin Nutr 120(5):1009\u20131018. https:\/\/doi.org\/10.1016\/j.ajcnut.2024.08.027","journal-title":"Am J Clin Nutr"},{"key":"2477_CR21","doi-asserted-by":"publisher","first-page":"102595","DOI":"10.1016\/j.redox.2022.102595","volume":"59","author":"Y Xi","year":"2023","unstructured":"Xi Y, Zhang Y, Zhou Y, Liu Q, Chen X, Liu X et al (2023) Effects of methionine intake on cognitive function in mild cognitive impairment patients and APP\/PS1 alzheimer\u2019s disease model mice: role of the cystathionine-\u03b2-synthase\/H(2)S pathway. Redox Biol 59:102595. https:\/\/doi.org\/10.1016\/j.redox.2022.102595","journal-title":"Redox Biol"},{"issue":"48","key":"2477_CR22","doi-asserted-by":"publisher","first-page":"15225","DOI":"10.1021\/acs.jafc.2c04847","volume":"70","author":"Y Yang","year":"2022","unstructured":"Yang Y, Lu M, Xu Y, Qian J, Le G, Xie Y (2022) Dietary methionine via Dose-Dependent Inhibition of Short-Chain fatty acid production capacity contributed to a potential risk of cognitive dysfunction in mice. J Agric Food Chem 70(48):15225\u201315243. https:\/\/doi.org\/10.1021\/acs.jafc.2c04847","journal-title":"J Agric Food Chem"},{"issue":"1","key":"2477_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bnd.2024.10.006","volume":"1","author":"C Yue","year":"2025","unstructured":"Yue C, Fu Y, Zhao Y, Ou Y, Sun Y, Tan L (2025) Association between alzheimer\u2019s disease and metabolic syndrome: unveiling the role of dyslipidemia mechanisms. Brain Netw Disorders 1(1):21\u201327. https:\/\/doi.org\/10.1016\/j.bnd.2024.10.006","journal-title":"Brain Netw Disorders"},{"issue":"6","key":"2477_CR17","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.molcel.2019.06.039","volume":"75","author":"W Yu","year":"2019","unstructured":"Yu W, Wang Z, Zhang K, Chi Z, Xu T, Jiang D et al (2019) One-Carbon metabolism supports S-Adenosylmethionine and histone methylation to drive inflammatory macrophages. Mol Cell 75(6):1147\u201360e5. https:\/\/doi.org\/10.1016\/j.molcel.2019.06.039","journal-title":"Mol Cell"},{"key":"2477_CR46","doi-asserted-by":"publisher","unstructured":"Zhang K, Jiang L, Xue L, Wang Y, Sun Y, Fan M et al (2023) The enhancement of acylcarnitine metabolism by 5-Heptadecylresorcinol in brown adipose tissue contributes to improving glucose and lipid levels in aging male mice. Nutrients 15(21). https:\/\/doi.org\/10.3390\/nu15214597","DOI":"10.3390\/nu15214597"},{"issue":"2","key":"2477_CR23","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1021\/acs.jafc.4c09878","volume":"73","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Liu T, Pan F, Li Y, Wang D, Pang J et al (2025) Dietary methionine restriction alleviates cognitive impairment in alzheimer\u2019s disease mice via Sex-Dependent modulation on gut microbiota and Tryptophan metabolism: A multiomics analysis. J Agric Food Chem 73(2):1356\u20131372. https:\/\/doi.org\/10.1021\/acs.jafc.4c09878","journal-title":"J Agric Food Chem"},{"key":"2477_CR55","doi-asserted-by":"publisher","first-page":"934070","DOI":"10.3389\/fnagi.2022.934070","volume":"14","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Dong X, Chen B, Zhang Y, Meng S, Guo F et al (2022) Blood levels of Circulating methionine components in alzheimer\u2019s disease and mild cognitive impairment: A systematic review and meta-analysis. Front Aging Neurosci 14:934070","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"2477_CR56","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/156720510790691326","volume":"7","author":"JM Zhuo","year":"2010","unstructured":"Zhuo JM, Portugal GS, Kruger WD, Wang H, Gould TJ, Pratico D (2010) Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of alzheimer\u2019s disease. Curr Alzheimer Res 7(2):140\u2013149. https:\/\/doi.org\/10.2174\/156720510790691326","journal-title":"Curr Alzheimer Res"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02477-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-026-02477-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02477-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:43:16Z","timestamp":1774402996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-026-02477-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["2477"],"URL":"https:\/\/doi.org\/10.1007\/s12031-026-02477-1","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"This study was conducted using ADNI data. The ADNIstudy is ethically approved and operated in accordance with the Declaration of Helsinki, 1964.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent To Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial"}}],"article-number":"35"}}